Home/Evommune/J. Mark Jackson, M.D.
JM

J. Mark Jackson, M.D.

Senior Vice President, Clinical Development

Evommune

Evommune Pipeline

DrugIndicationPhase
EVO756Chronic Spontaneous UrticariaPhase 2b
EVO301Atopic DermatitisPhase 2